Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Drake, Charles G."" wg kryterium: Autor


Tytuł:
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
Autorzy:
Miao D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Margolis CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Gao W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Voss MH; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Weill Cornell Medical College, New York, NY 10065, USA.
Li W; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Martini DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Norton C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Bossé D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Wankowicz SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Cullen D; Bristol-Myers Squibb, New York, NY 10154, USA.
Horak C; Bristol-Myers Squibb, New York, NY 10154, USA.
Wind-Rotolo M; Bristol-Myers Squibb, New York, NY 10154, USA.
Tracy A; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Drake CG; Columbia University Medical Center, New York, NY 10032, USA.
Ball MW; James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Allaf ME; James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Snyder A; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Hellmann MD; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Weill Cornell Medical College, New York, NY 10065, USA.
Ho T; Mayo Clinic, Scottsdale, AZ 85259, USA.
Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Weill Cornell Medical College, New York, NY 10065, USA.
Signoretti S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. eliezerm__.
Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. eliezerm__.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2018 Feb 16; Vol. 359 (6377), pp. 801-806. Date of Electronic Publication: 2018 Jan 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
B7-H1 Antigen/*antagonists & inhibitors
Carcinoma, Renal Cell/*genetics
Carcinoma, Renal Cell/*therapy
Immunotherapy/*methods
Kidney Neoplasms/*genetics
Kidney Neoplasms/*therapy
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
CTLA-4 Antigen/antagonists & inhibitors ; Chromosomal Proteins, Non-Histone/genetics ; Cohort Studies ; Exome/genetics ; Gene Expression Profiling ; Genomics ; Humans ; Mutation ; Transcription Factors/genetics
Czasopismo naukowe
Tytuł:
LAG3 (CD223) as a cancer immunotherapy target.
Autorzy:
Andrews LP; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Marciscano AE; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
Drake CG; Departments of Oncology, Immunology and Urology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
Vignali DA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Tumor Microenvironment Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
Immunological reviews [Immunol Rev] 2017 Mar; Vol. 276 (1), pp. 80-96.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Antibodies, Monoclonal/*therapeutic use
Antigens, CD/*metabolism
Immunotherapy/*methods
Neoplasms/*therapy
T-Lymphocytes/*immunology
Animals ; Antigens, CD/genetics ; Antigens, CD/immunology ; Clinical Trials as Topic ; Disease Models, Animal ; Humans ; Lymphocyte Activation ; Mice ; Neoplasms/immunology ; Programmed Cell Death 1 Receptor/genetics ; Programmed Cell Death 1 Receptor/immunology ; Programmed Cell Death 1 Receptor/metabolism ; Signal Transduction ; Tumor Escape ; Tumor Microenvironment ; Lymphocyte Activation Gene 3 Protein
Czasopismo naukowe
Tytuł:
Immune modulation and stereotactic radiation: improving local and abscopal responses.
Autorzy:
Zeng J; Department of Radiation Oncology, University of Washington, 1959 NE Pacific Street, P.O. Box 356043, Seattle, WA 98195, USA.
Harris TJ
Lim M
Drake CG
Tran PT
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2013; Vol. 2013, pp. 658126. Date of Electronic Publication: 2013 Nov 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms:
Immunotherapy*
Radiosurgery*
Neoplasms/*radiotherapy
Combined Modality Therapy ; Humans ; Neoplasms/immunology ; Neoplasms/pathology ; Radiation Dosage
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies